Trademarkia Logo

Australia

AU$
HEMOXMOD
Cancelled: Cancelled at the request of IB

Last updated on 30 Sept 2022

Owner Info

Global Blood Therapeutics, Inc.

181 Oyster Point Boulevard

South San Francisco CA 94080, UNITED STATES OF AMERICA

Serial Number

1948738 filed on 11 Jun 2018

Correspondent

Harold Milstein Sheppard Mullin Richter & Hampton LLP

379 Lytton Avenue,

Palo Alto CA 94301,

UNITED STATES OF AMERICA

HEMOXMOD

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of Read More

Mark Details


Serial Number

1948738

Registered On

11 Jun 2018

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

14 Dec 2017

Mark Type

US

Legal History


Show more

Status DateAction Taken
30th Sept 2022Status change to Voided
4th Mar 2021Amendment to Amend Owner Requested
4th Apr 2019IP Right Registration Published
4th Apr 2019International Registration in Australia Protected correspondence sent
4th Apr 2019Status change to Registered/Protected
28th Jan 2019Application Accepted correspondence sent
28th Jan 2019IP Right Acceptance Published
28th Jan 2019IP Right has been Examined
28th Jan 2019Status change to Accepted
30th Aug 2018IP Right Filed Published